Evidence map›Paper›PMID 33979546›Full record

ReviewAnnual review of analytical chemistry (Palo Alto, Calif.)2021

Active Flow Control and Dynamic Analysis in Droplet Microfluidics.

Nan Shi, Md Mohibullah, Christopher J Easley

Abstract readReview
In one paragraph

Review in Annual review of analytical chemistry (Palo Alto, Calif.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Dynamic sampling fromLab on a chip · 2024
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nan ShiDepartment of Chemistry and Biochemistry, Auburn University, Auburn, Alabama 36849, USA; email: chris.easley@auburn.edu.
Md MohibullahDepartment of Chemistry and Biochemistry, Auburn University, Auburn, Alabama 36849, USA; email: chris.easley@auburn.edu.
Christopher J EasleyDepartment of Chemistry and Biochemistry, Auburn University, Auburn, Alabama 36849, USA; email: chris.easley@auburn.edu.

Funding

Unmasking mechanisms of lipolytic dynamics in adipose tissue using high-resolution microfluidic samplingR01DK093810 · NIDDK · AUBURN UNIVERSITY AT AUBURN · PI EASLEY, CHRISTOPHER J · 2012 to 2023
$3.8M
NIDDK NIH HHS R01 DK093810
6 · The paper itself

Abstract

Droplet-based microfluidics has emerged as an important subfield within the microfluidic and general analytical communities. Indeed, several unique applications such as digital assay readout and single-cell sequencing now have commercial systems based on droplet microfluidics. Yet there remains room for this research area to grow. To date, most analytical readouts are optical in nature, relatively few studies have integrated sample preparation, and passive means for droplet formation and manipulation have dominated the field. Analytical scientists continue to expand capabilities by developing droplet-compatible method adaptations, for example, by interfacing to mass spectrometers or automating droplet sampling for temporally resolved analysis. In this review, we highlight recently developed fluidic control techniques and unique integrations of analytical methodology with droplet microfluidics-focusing on automation and the connections to analog/digital domains-and we conclude by offering a perspective on current challenges and future applications.

Indexed as

Microfluidic Analytical TechniquesMicrofluidicsBiological AssayMass Spectrometryanalog and digital informationdropletsdynamic analysismicrofluidicsprogrammable

Identifiers

PMID33979546
PMCPMC8956363

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.